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Abstract
-Peptides made from L-aspartic acid monomers form a new class of 3-peptides. Here we
report the first three-dimensional NMR solution structure of a 3-hexapeptide (1) from L-aspartic
acid monomers in 2,2,2-trifluoroethanol (TFE). We show that 1 forms a right-handed 14-helical
structure in TFE. -peptides from naturally occurring L-amino acids adopt a right-handed -helix
whereas -peptides formed from -amino acids derived from naturally occurring L-amino acids
form left-handed 14-helices. The right-handed 14-helical conformation of 1 is a better mimic of
-peptide conformations.

Using the NMR structure of 1 in TFE, we further study the

conformation of 1 in water, as well as two similar 3-peptides (2 and 3) in water and TFE by
molecular dynamics (MD) simulations. NMR and MD results suggest loss of secondary structure
of 1 in water and show that it forms a fully extended structure. 2 and 3 contain residues with
oppositely charged side chains that engage in salt-bridge interactions and dramatically stabilize
the 14-helical conformation in aqueous media.

Abbreviations:

CD, circular dichroism; MD, molecular dynamics; NMR, nuclear magnetic

resonance spectroscopy; NOE, nuclear Overhauser effect; NOESY, two-dimensional NOE
spectroscopy; ns, nanosecond; pbc, periodic boundary conditions; ps, picosecond; RMSD, root
mean square deviation; TFE, 2,2,2-trifluoroethanol; SPC, simple point charge
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1.

Introduction
-peptide foldamers are interesting from a pharmaceutical standpoint as mimics of -peptides

since they are not susceptible to proteolysis and metabolism [1-6]. -peptides contain one
additional methylene group in the backbone compared to the -peptides. They are subdivided
into mainly three types, namely, 3-, 2-, and 2,3-peptides, depending upon the substitution of the
backbone carbon.

The substitution pattern dictates the solution conformation of these

peptidomimetics. In general, monosubstituted 3- or 2-peptides form 14-helical structures and
alternating 2/3-peptides prefer 10/12 helices.

-peptides that fold into stable 14-helical

conformations have received particular attention [7-12].

The helical secondary structure is

enhanced by the presence of organic solvents, such as methanol and 2,2,2-trifluoroethanol (TFE),
and efforts have been made to stabilize this conformation in aqueous solutions [13-17].
Introduction of constraints like cyclic ring systems, salt-bridge formation, or neutralization of the
helix macrodipole have been utilized to obtain stable helical structures in aqueous media [13, 18,
19].

-peptides are made from -amino acid monomers using solid-phase synthesis, while the amino acids themselves are synthesized by homologotion of -amino acids [12, 20]. We have
recently reported the synthesis of novel -peptides from L-aspartic acid monomers [21]. The
synthetic strategy employed allowed easy access to a wide variety of side chains by coupling of a
free amine to the side chain -carboxylic group of aspartic acid. This procedure introduces an
extra amide bond in the side chain of the -peptide scaffold making them more polar than the
previously reported -peptides (Figure 1a).

However, this extra amide bond provides

opportunities for more hydrogen-bonding capabilities and is speculated to give unprecedented
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secondary structure in this class of -peptides. Furthermore, the stereochemistry at the  carbon
is opposite in these two classes of -peptides (Figure 1a).

Here, we study the solution conformation of few representative 3-peptides (Figure 1b) from Laspartic acid monomers. Using NMR spectroscopy and MD simulations, we have determined the
three-dimensional structure of a 3-hexapeptide 1 in 2,2,2-trifluoroethanol (TFE). We show that
1 forms a right-handed 14-helical structure in TFE. In contrast, the reported -peptides formed
from -amino acids derived from naturally occurring L-amino acids form left-handed 14 helices
[1, 4]. The right-handed 14-helical conformation of 1 is a better mimic of right-handed -helix of
-peptides (Figure 2). The NMR solution structure of 1 in TFE is further used to study the
conformation of 1, as well as two similar 3-hexapeptides (2 and 3) in water and TFE by
molecular dynamics (MD) simulations.

Six independent simulations, each of 10 or 20 ns

duration, were conducted with 3-peptides immersed in water or TFE with appropriate salt
concentrations. The results from these simulations suggest that a salt-bridge interaction between
the side chain residues is required for maintaining the helical conformation in water. The
different conformations acquired by these peptides in the two solvent systems are discussed.

Fig. 1. (a) Chemical structure of 3-peptide from L-aspartic acid monomers (left) and 3peptides from 3-amino acids derived from natural L-amino acids (right). (b) Chemical
structure of 3-peptides from L-aspartic acid monomers (1, 2, and 3) studied here.

Fig. 2. Backbone conformation of right-handed -helix in an -peptide and 14-helix in a peptide from L-aspartic acid monomers. N and C stand for N- and C-terminus of the
peptides, respectively.
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2. Methods
2.1. NMR Structure Calculation
The NMR sample of previously synthesized 1 [21] was prepared in 100% TFE-d2
(CF3CD2OH) (Cambridge Isotope Laboratories, Inc.).

Sequence specific assignments were

established by following the procedures used for -amino acid peptides [22]. The complete
chemical shift assignments for 1 are listed in Table 1. 2D TOCSY (60 ms mixing time), COSY
and NOESY (mixing time 100, 200 and 300 ms) spectra were recorded at 10C on a Varian
INOVA 500 MHz spectrometer equipped with an HCN cold probe and pulsed-field gradients.
153 upper distance restraints for structure calculations were obtained from a 300 ms mixing time
2D-[1H,1H]-NOESY recorded at 10C on a Varian INOVA 800 MHz NMR spectrometer,
equipped with an HCN cold probe and pulsed-field gradients. Calculation of the complete threedimensional structure was performed with the program CYANA v 2.1 [23]. Input data and
structure calculation statistics are summarized in Table 2. The final calculation was started with
200 randomized conformers all of which converged to the helical conformation (average
backbone RMSD to mean for 200 structures: 0.61 ± 0.21 Å). A bundle of the 10 lowest energy
CYANA conformers were used to represent the NMR structure. The NMR structure of 1 showed
a well-defined 14-helical conformation that was further optimized by 10 ns MD simulation in
TFE as described below.

Table 1: Chemical shift assignments for 3-hexapeptide 1.

Table 2. Structure calculation statistics for 3-hexapeptide 1.

2.2. Molecular Dynamics Simulations
5

The NMR structure obtained for 1 using CYANA was further subjected to molecular dynamics
(MD) simulations using GROMACS [24, 25] as described previously [26, 27]. Simulation
systems were generated by placing 1 (pdb coordinates from CYANA) in a cubic box with an edge
length of ca. 4 nm, followed by solvation of the peptide using 2,2,2-trifluoroethanol (TFE).
Sufficient counterions were added to make the system electroneutral and to provide a final
concentration of ~25 M NaCl. All the amines including the N-terminal amine were positively
charged giving the peptide a net charge of +3. The details of the periodic cell for simulation
system are listed in Table 3. The system was initially subjected to 1000 steps of the steepest
descent energy minimization.

The peptide coordinates of the resulting system were then

restrained, while allowing solvent molecules to relax their positions and optimize interactions
with the peptide during a 200 ps positional-restraint simulation. After initial equilibration, 10 ns
MD simulation was run. Simulation was analyzed using GROMACS routines. SwissPDB
Viewer [28] and WebLab ViewerLite [29] were used to visualize structures. The root-meansquare deviation (RMSD) analysis of the peptide (all residues) showed that the MD structure of 1
is very similar to the initial NMR structure. Visualization of the snapshots from the simulation
also showed no difference in NMR structure and the MD structures in TFE. Thus the average
structure obtained from the last 1 ns of the MD simulation was used as the final structure of 1 and
was used for all subsequent MD simulations.

Table 3: Details of MD simulations in the NPT ensemble.

Structure of 1 in TFE was used as the initial structure for water simulation. The system was
setup by placing 1 in a cubic box and the box was filled with SPC water molecules and a 20 ns
simulation was conducted as described above.
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Initial structures for peptides 2 and 3 were generated by replacing the side chains in 1 (TFE
structure) using builder module of Insight II (Accelrys Software Inc.). 1 and 2 differ by one
residue. 1 consists of two basic lysine mimicking side chains at positions 2 and 5, whereas 2
contains one lysine mimicking side chain at position 2 and a negatively charged carboxylate side
chain at position 5. The length of the side chains (4 CH2 at position 2 and 3 CH2 at position 5)
was such that it maximizes the salt-bridge interaction. 3 contains two pairs of oppositely charged
side chains, ornithine mimicking side chains at positions 1 and 2, and glutamate mimics at
position 4 and 5. The side chain length was reduced (by one CH2 as compared to 1 and 2) as it
has been suggested that shorter side chains are better for 14-helix stability [15].

Simulations for 2 and 3 in TFE and water were conducted as mentioned above. All the amines
were protonated and carboxylate(s) unprotonated giving both the peptides a net charge of +1. The
details of the periodic cell for each system, including the number of water or TFE molecules, the
initial box size, and, the duration of simulations are listed in Table 3.

3. Results and Discussion
Our primary goal is to investigate the solution conformation of 3-peptides from L-aspartic
acid monomers. To probe the secondary structure of these -peptides, we have elucidated the
conformation of the previously synthesized hexapeptide 1 [21] in TFE using NMR spectroscopy.
Analysis of CD spectra of 1 in TFE previously showed the appearance of characteristic peaks for
the 14-helical conformation in -peptides [21]. A maximum near 195 nm and minimum at 214
nm was observed. The NMR spectrum of 1 in TFE further confirms the presence of a stable
secondary structure. The well dispersed chemical shifts in the amide region allowed assignment
of all the backbone and side chain protons (Figure 3 top).
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A two-dimensional NOESY

experiment performed at 10C in CF3CD2OH showed multiple (five out of six possible) longrange CH(i)  CH(i+3) NOEs (protons at -carbon are not stereospecifically assigned) (Figure
4).

These peaks are a hallmark of 14-helical secondary structure [10, 15, 30].

A three-

dimensional structure of 1 was obtained using the NOE data and the program CYANA [23] as
described in the Methods section. The pdb coordinates of the structure (average of 10 structures,
rmsd of all backbone atoms 0.47 ± 0.11 Å) obtained from CYANA were subjected to molecular
dynamics simulations in TFE using GROMACS software [24, 25]. MD simulations in explicit
solvent systems complement the NMR data and are a valuable tool for obtaining the final solution
structure that is representative of the ensemble of solution structures [31-33]. Figure 5 shows the
final structure of 1 in TFE after 10 ns MD simulation. 1 forms a right-handed 14-helical structure
with a radius of 2.6 Å and 4.69 Å rise/turn, similar to the reported left-handed 3-peptides [1, 4].
The helical structure was maintained throughout the 10 ns simulation in TFE.

Fig. 3. 1D NMR of 3-peptide 1 showing the amide H-atoms in 100% TFE-d2 (top) and
90% H2O/10% D2O (bottom). HN refers to the backbone amide proton and HS refers to the
one in the side chain. The number in the parentheses is for the number of overlapping peaks
and impurities are marked with *.

Fig. 4. 2D NOESY of 3-peptide 1 in TFE showing the long range NOEs, CH(i)-CH(i+3)
characteristic of 14-helix conformation.

Fig. 5. Solution structure of 3-hexapeptide 1 in TFE obtained by NMR and MD simulation.
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1 lost all the secondary structure in water as evidenced by the limited dispersion of amide
chemical shifts in NMR (Figure 3 bottom). Asp-derived 3-peptides are expected to be more
soluble than the “normal” 3-peptides. Therefore, 1 should be less prone to self-associate in water
compared to analogous sequences with similar distribution of hydrophobic side chains as shown
by Gellman and coworkers [34]. The CD spectrum of 1 in water previously indicated the
presence of no secondary structure [21]. A 20 ns MD simulation of 1 in water (starting with the
helical structure) showed dramatic conformational changes. The overall peptide stability was
measured by plotting the RMSD of the peptide structure fitted onto its initial structure as a
function of time (Figure 6).

The RMSD values suggested stabilization of the peptide

conformation (1) in TFE. However, simulation in water showed destabilization of the peptide
conformation during most of the simulation.

Further analysis of the trajectories showed

maximum conformational changes of 1 in water in the first 12 ns of the simulation with
stabilization of the fully extended structure towards the end. Figure 7 depicts snapshots of 1 at
five instants (0, 2, 10, 16, and 20 ns) during simulation in water.

Fig. 6. RMSD of 3-peptide 1 during MD simulation in TFE (a) and water (b). RMSD was
calculated with respect to the initial NMR structure in TFE obtained from CYANA.

Fig. 7. Snapshots from MD simulation of 3-peptide 1 in water.

We next explored the conformation of 2 and 3 in TFE and water using MD simulations. 2 and
3 contain oppositely charged (amine and carboxylate) side chains at the i and i+3 positions to
enhance intramolecular salt bridge formation, thereby stabilizing the helical conformation. 2 and
3 consist of one and two pairs of oppositely charged side chains, respectively. Both the peptides
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displayed a well-defined helical structure in TFE throughout the simulation. In water, the overall
structure was less rigid compared to that observed in TFE.

Figure 8 shows the average structures of 3-peptides 2 and 3 in TFE and water obtained from
the last 1 ns of the respective MD simulations. The distance between the backbone amide proton
of residue i and amide oxygen of residue i+3 was used to judge the presence of the 14-helical
conformation. A distance of about 2.5 Å was considered to be a C=O∙∙∙H─N hydrogen bond [32].
For all the peptides (1, 2, and 3), at least three of these hydrogen bonds were observed in TFE
throughout the simulation. These distances are listed in Table 2 averaged over the final 1 ns of
the simulations in TFE. During water simulations, helical structure was only maintained by
peptide 3, and to some extent by peptide 2 as shown by the hydrogen bond distance between i and
i+3 backbone amide atoms (Table 3).

Fig. 8. Structures of 2 in TFE (a) and water (b), and 3 in TFE (c) and water (d) obtained by
MD simulations.

The helical conformation of 2 and 3 was better maintained compared to 1. A cluster analysis
of the simulations in water showed that there were 653, 422, and 189 clusters present during the
20 ns simulations in water of peptides 1, 2, and 3, respectively (Table 3). Each cluster represents
a discrete structure that is different from the other cluster and is created based on the RMS
deviation of all atoms of the peptide. The number of clusters obtained during simulation in water
suggests that although the presence of two salt-bridges in 3 stabilizes the helical conformation
dramatically, the overall structure is still flexible in water (189 clusters). In comparison, only one
or two clusters were present for 1, 2 or 3 during simulations in TFE. 3-peptides with oppositely
charged residues at i and i+3 positions are known to form helix stabilizing intramolecular salt
10

bridges [13-16], and a similar strategy for enhancing helical stability seem to work for these novel
3-peptides (with an amide bond in the side chain) as well. Interestingly, the side chain amide
protons were not found to engage in any permanent (or long-lasting) hydrogen bond interaction in
the helical or other conformations in any of the peptides in either TFE or water.

4. Conclusion
We have studied the solution conformation of a novel class of 3-peptides derived from Laspartic acid monomers using NMR spectroscopy and MD simulations.

These 3-peptides

contain an additional amide bond in the side chain that provides opportunities for additional
hydrogen bonds and is speculated to give unprecedented secondary structures in this class of peptides. The NMR solution structure of a representative 3-hexapeptide 1 shows that it forms a
right-handed 14-helical structure in TFE. This helical conformation is same as the 14-helical
conformation for the 3-peptides which do not have an additional amide bond in the side chain.
However, 1 forms a right-handed helix and the 3-peptides obtained from the 3-amino acids
derived from L-amino acids form left-handed helices, most likely due to the opposite
stereochemistry at the 3 carbon in the peptide backbone. Furthermore, using MD simulations it
was found that the helical conformation in 1 can be stabilized in water by introduction of side
chain salt-bridges, such as in peptides 2 and 3. Using this structural information, 3-peptides that
mimic biologically active -peptides are being currently designed and optimized.
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Fig. 1. (a) Chemical structure of 3-peptide from L-aspartic acid monomers (left) and 3peptides from 3-amino acids derived from natural L-amino acids (right). (b) Chemical
structure of 3-peptides from L-aspartic acid monomers (1, 2, and 3) studied here.
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Fig. 2. Backbone conformation of right-handed -helix in an -peptide and 14-helix in a peptide from L-aspartic acid monomers. N and C stand for N- and C-terminus of the peptides,
respectively.
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Table 1. Chemical shift assignments for 3-hexapeptide 1.

Residue
1

Backbone shifts
Side chain shifts
7.84 (HN), 4.25 (HA),
7.46 (HS), 4.03 (HG), 1.17, 1.22 (HDs)
2.84, 3.61 (HBs)
2
8.78 (HN), 5.04 (HA),
7.43 (HS), 3.22, 3.28 (HGs), 1.61 (HDs), 1.70 (HEs),
2.61, 3.20 (HBs)
3.01 (HEs), 7.32 (HR)
3
9.10 (HN), 4.86 (HA),
6.90 (HS), 3.06 (HGs), 1.76 (HD), 0.90 (HEs)
2.57, 3.08 (HBs)
4
8.58 (HN), 5.03 (HA),
8.24 (HS), 4.01 (HG), 1.20 (HDs)
2.54, 2.73 (HBs)
5
7.32 (HN), 5.22 (HA),
8.26 (HS), 3.20, 3.28 (HGs), 1.61 (HDs), 1.70 (HEs),
2.64, 2.73 (HBs)
3.01 (HEs), 7.20 (HR)
6
7.24 (HN), 5.22 (HA),
8.28 (HS), 2.98, 3.08 (HGs), 1.81 (HD), 0.90 (HEs)
2.71 (HBs)
C-terminus 6.73, 6.92 (NH2)
The final concentration of 1 in TFE was 1.5 mM. The chemical shifts were referenced to the
TFE methylene protons at 2.88 ppm
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Table 2. Structure calculation statistics for 3-hexapeptide 1.

NOE upper distance limitsa
Intra-residue
Sequential
Medium range (i to i+2 or i+3)
Final CYANA structuresb
CYANA target function
Average backbone RMSD to mean
Average heavy atom RMSD to mean
Distance restraint violations

153
102
21
30

0.17 ± 0.002 Å2
0.47 ± 0.11 Å
1.31 ± 0.23 Å
0
a
148 unambiguous NOEs and 5 ambiguous NOEs used for the structure
calculation. b10 lowest energy structures of the 200 calculated.
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Table 3. Details of MD simulations in the NPT ensemble.

-peptidea Total number Duration No. of
of solvent
(ns)
Atoms
molecules

Approx.
box size
(nm)

Distance between
i and i+3 NH-CO (Å)b

Number
of
clusters
1
653

1
1

420 TFE
2124 H2O

10
20

3040
6472

4x4x4
4x4x4

2.01 2.04 2.77
-

2
2

417 TFE
2121 H2O

10
20

3015
6459

4x4x4
4x4x4

2.01
4.03
3.80
5.60

3
3

416 TFE
2121 H2O

10
20

3012
6463

4x4x4
4x4x4

2.15 2.10 2.18
1.85 1.92 2.20

2.04
2.19
2.93
2.47

2.70
2
2.08 (15 ns)
422
2.98 (16 ns)
5.02 (19-20 ns)
2
189

A simulation box consists of a -peptide soaked in TFE or water molecules along with ions to
maintain electroneutrality and a final concentration of 25 M sodium chloride. bThe distance
between i and i+3 NH-CO refers to hydrogen bond distance between the hydrogen and the
oxygen atoms (averaged over the last 1 ns of the simulation) of the backbone amide for a 14helical conformation.
a
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Fig. 3. 1D NMR of 3-peptide 1 showing the amide H-atoms in 100% TFE-d2 (top) and 90%
H2O/10% D2O (bottom). HN refers to the backbone amide proton and HS refers to the one in the
side chain. The number in the parentheses is for the number of overlapping peaks and impurities
are marked with *.
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Fig. 4. 2D NOESY of 3-peptide 1 in TFE showing the long range NOEs, CH(i)-CH(i+3)
characteristic of 14-helix conformation.
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Fig. 5. Solution structure of 3-hexapeptide 1 in TFE obtained by NMR and MD simulation.
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Fig. 6. RMSD of 3-peptide 1 during MD simulation in TFE (a) and water (b). RMSD was
calculated with respect to the initial NMR structure in TFE obtained from CYANA.
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Fig. 7. Snapshots from MD simulation of 3-peptide 1 in water.
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(a)

(c)

(b)

(d)

Fig. 8. Structures of 2 in TFE (a) and water (b), and 3 in TFE (c) and water (d) obtained by MD
simulations.
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